Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice

Abstract Background Sodium glucose co-transporter2 inhibitors reduce the incidence of cardiovascular events in patients with type 2 diabetes mellitus based on the results of recent cardiovascular outcome studies. Herein, we investigated the effects of long-term treatment with canagliflozin on bioche...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Νarjes Nasiri-Ansari, Georgios K. Dimitriadis, Georgios Agrogiannis, Despoina Perrea, Ioannis D. Kostakis, Gregory Kaltsas, Athanasios G. Papavassiliou, Harpal S. Randeva, Eva Kassi
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2018-07-01
Edice:Cardiovascular Diabetology
Témata:
Canagliflozin
SGLT2i
Atherosclerosis
Inflammation
APOE knockout mice
On-line přístup:http://link.springer.com/article/10.1186/s12933-018-0749-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky